Trials / Completed
CompletedNCT03665506
Trifluridin/tipirACil in MeTastatIc Colorectal Cancer
A Non-interventional Study to Assess Effectiveness and Safety of Trifluridin/tipiracil in Patients with Metastatic Colorectal Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 315 (actual)
- Sponsor
- Servier · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A non-interventional, prospective, open, multicenter study in Germany in patients with metastatic colorectal cancer who have been previously treated with, or are not considered candidates for, available therapies and with decision for treatment with trifluridin/tipiracil.
Detailed description
The purpose of this NIS, after market approval of trifluridin/tipiracil as treatment for mCRC patients who have been previously treated with, or are not considered candidates for, available therapies, is to evaluate effectiveness, QoL, treatment details and safety of trifluridin/tipiracil treatment in a real-world setting. In addition, therapy management and health economic parameters regarding trifluridin/tipiracil treatment will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trifluridin/Tipiracil | QoL assessment |
Timeline
- Start date
- 2018-06-25
- Primary completion
- 2021-08-02
- Completion
- 2021-08-02
- First posted
- 2018-09-11
- Last updated
- 2024-12-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03665506. Inclusion in this directory is not an endorsement.